The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Marc Fellous, MD
Sr. Vice President of Medical Affairs
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
77 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Chris O'Brien Lifehouse Hospital
Camperdown, New South Wales, Australia
Recruiting - Mater Cancer Care Centre
South Brisbane, Queensland, Australia
Recruiting - Flinders Medical Center
Bedford Park, South Australia, Australia
Recruiting - Monash Medical Centre
Clayton, Victoria, Australia
Recruiting - Linear Clinical Research
Nedlands, Western Australia, Australia
Recruiting
- Icans - Institut de Cancérologie Strasbourg Europe
Strasbourg, Bas-Rhin, France
Recruiting - Institut Bergonie
Bordeaux, Gironde, France
Recruiting - Institut Claudius Regaud
Toulouse, Haute-Garonne, France
Recruiting - Edog Institut de Cancerologie de L'Ouest
Saint-Herblain, Loire-Atlantique, France
Recruiting - Centre Jean Perrin
Clermont-Ferrand, Puy-de-Dôme, France
Recruiting - Institut Gustave Roussy
Villejuif, Val-de-Marne, France
Recruiting - Centre Léon Bérard Centre Régional de Lutte Contre Le Cancer
Lyon, France
Recruiting - Chu de Nîmes
Nîmes, France
Recruiting - Institute Cancer de Lorraine
Vandœuvre-lès-Nancy, France
Recruiting
- Nationale Centrum Für Tumorerkrankungen (nct) Heidelberg
Heidelberg, Baden-Wurttemberg, Germany
Recruiting - Universitätsklinikum Augsburg
Augsburg, Bavaria, Germany
Recruiting - Asklepios Klinik Altona
Hamburg, Free and Hanseatic City of Hamburg, Germany
Recruiting - Universitätsklinikum Frankfurt
Frankfurt am Main, Hesse, Germany
Withdrawn - Universitätsklinikum Essen
Essen, North Rhine-Westphalia, Germany
Recruiting
- Fondazione Policlinico Universitario Agostino Gemelli Irccs
Rome, Lazio, Italy
Recruiting - Istituti Fisioterapici Ospitalieri - Istituto Nazionale Tumori Regina Elena
Rome, Lazio, Italy
Recruiting - Asst Grande Ospedale Metropolitano Niguarda
Milan, Lombardy, Italy
Recruiting - Fondazione Irccs Istituto Nazionale Dei Tumori
Milan, Lombardy, Italy
Recruiting - Istituto Europeo Di Oncologia
Milan, Lombardy, Italy
Recruiting - Istituto Clinico Humanitas
Rozzano, Lombardy, Italy
Recruiting - Fondazione del Piemonte Per L'Oncologia (irccs)
Candiolo, Torino, Italy
Recruiting - Humanitas San Pio X
Milan, Italy
Recruiting - Irccs - Lstituto Nazionale Tumori - Fondazione G. Pascale
Naples, Italy
Recruiting
- National University Hospital
Kent Ridge, Singapore
Recruiting - National Cancer Center of Singapore
Singapore, Singapore
Recruiting
- Asan Medical Center
Seoul, South Korea
Recruiting - National Cancer Center
Seoul, South Korea
Recruiting - Samsung Medical Center
Seoul, South Korea
Recruiting - Seoul University Hospital
Seoul, South Korea
Recruiting - Severance Hospital Yonsei University
Seoul, South Korea
Recruiting
- Start Madrid_hospital Universitario Fundacion Jimenez Diaz
Madrid, Madrid, Spain
Recruiting - Start Madrid_hospital Universitario Hm Sanchinarro - Ciocc
Madrid, Madrid, Spain
Recruiting - Instituto de Investigacion Oncologica Vall D'Hebron (vhio) - Epon
Barcelona, Spain
Recruiting - Next Oncology-Hospital Quironsalud Barcelona
Barcelona, Spain
Recruiting - Hospital Universitario 12 de Octubre
Madrid, Spain
Recruiting
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 29 Oct 2020
- Primary completion
- 15 Aug 2026
- Completion
- 31 Dec 2027
- Last update posted
- 26 Jun 2026
- Registered enrollment
- 300
- Registry id
- NCT04585750
Cross-registrations
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.